Cargando…
Mesenchymal stem cells-bridge catalyst between innate and adaptive immunity in COVID 19
Majority of patients infected with the COVID 19 virus display a mild to moderate course of disease and spontaneously recover at 14–20 days. However, about 15% of patients progress to severe stages and 2.5% of these patients succumb to this illness. Most patients with severe disease belong to the eld...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232064/ https://www.ncbi.nlm.nih.gov/pubmed/32425307 http://dx.doi.org/10.1016/j.mehy.2020.109845 |